These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Salinsky MC; Binder LM; Oken BS; Storzbach D; Aron CR; Dodrill CB Epilepsia; 2002 May; 43(5):482-90. PubMed ID: 12027908 [TBL] [Abstract][Full Text] [Related]
43. Gabapentin in the management of convulsive disorders. McLean MJ Epilepsia; 1999; 40 Suppl 6():S39-50; discussion S73-4. PubMed ID: 10530682 [TBL] [Abstract][Full Text] [Related]
44. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy. Goa KL; Sorkin EM Drugs; 1993 Sep; 46(3):409-427. PubMed ID: 7693432 [TBL] [Abstract][Full Text] [Related]
45. Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine. Sethi A; Chandra D; Puri V; Mallika V Neurol India; 2002 Sep; 50(3):359-63. PubMed ID: 12391470 [TBL] [Abstract][Full Text] [Related]
46. Gabapentin--a new antiepileptic drug. Drug Ther Bull; 1994 Apr; 32(4):29-30. PubMed ID: 7635023 [TBL] [Abstract][Full Text] [Related]
47. Differential cognitive effects of carbamazepine and gabapentin. Meador KJ; Loring DW; Ray PG; Murro AM; King DW; Nichols ME; Deer EM; Goff WT Epilepsia; 1999 Sep; 40(9):1279-85. PubMed ID: 10487192 [TBL] [Abstract][Full Text] [Related]
48. Gabapentin add-on treatment: how many patients become seizure-free? An open-label multicenter study. Mayer T; Schütte W; Wolf P; Elger CE Acta Neurol Scand; 1999 Jan; 99(1):1-7. PubMed ID: 9925232 [TBL] [Abstract][Full Text] [Related]
49. [Gabapentin as adjuvant therapy in the treatment of refractory partial epilepsy]. Tomović M; Ilić T; Mihajlović M; Jovicić A Vojnosanit Pregl; 1999; 56(2):151-6. PubMed ID: 10437420 [TBL] [Abstract][Full Text] [Related]
50. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77. Chadwick DW; Anhut H; Greiner MJ; Alexander J; Murray GH; Garofalo EA; Pierce MW Neurology; 1998 Nov; 51(5):1282-8. PubMed ID: 9818846 [TBL] [Abstract][Full Text] [Related]
51. [Gabapentin in children and adolescents with epilepsy]. Herranz JL Rev Neurol; 2002 Feb 16-28; 34(4):384-7. PubMed ID: 12022057 [TBL] [Abstract][Full Text] [Related]
52. [Gabapentin in 50 patients with epilepsy]. Gracia-Fleta F; Medrano-Martínez V; Castaño-Pérez MD; Hernández-Lorido R; Mañes R Rev Neurol; 2001 Jan 1-15; 32(1):45-9. PubMed ID: 11293098 [TBL] [Abstract][Full Text] [Related]
53. Gabapentin: a new agent for the management of epilepsy. Andrews CO; Fischer JH Ann Pharmacother; 1994 Oct; 28(10):1188-96. PubMed ID: 7841578 [TBL] [Abstract][Full Text] [Related]
55. Efficacy and safety of gabapentin as an add-on therapy in refractory partial epileptic patients. Towanabut S; Rungreangyingyod L; Suthisisang C J Med Assoc Thai; 2001 Apr; 84(4):554-61. PubMed ID: 11460968 [TBL] [Abstract][Full Text] [Related]
56. Gabapentin. Chadwick D Epilepsy Res Suppl; 1991; 3():183-6. PubMed ID: 1777078 [No Abstract] [Full Text] [Related]